Home Life Science Seattle-Based Pharma Co. Awarded $74MM DOD Contract for Drug Production
Life Science

Seattle-Based Pharma Co. Awarded $74MM DOD Contract for Drug Production

Share
Share
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announ
Thank you for your interest in The Registry. You must Subscribe or Log In to read the rest of this content.
Share

2026 Pacific Northwest CRE Rising Stars

PNW CRE Rising Stars

Featured Posts


Recent Posts

Related Articles

Seattle Life Science Stays Tightest of West Coast Hubs as New Construction Halts

Seattle's life science market entered the second half of 2026 with the...

Genentech to Invest $750MM to Double Hillsboro Manufacturing Campus

Genentech will invest approximately $750 million to double its Hillsboro, Oregon manufacturing...

Breakthrough Properties Acquires Stalled Seagen Biologics Plant in Everett for $78MM

A biomanufacturing facility that Pfizer abandoned two years into a $500 million...

Create a free account, or log in.

Gain access to read this article, plus limited free content.

Yes! I would like to receive new content and updates.